SCHEMBL29643300

SCHEMBL29643300

[C-]#[N+]c1ccc(C(F)(F)F)cc1I

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN5 P54829 1/20 0.34
GPR3 P46089 1/20 0.34
AR P10275 1/20 0.34
CES2 O00748 2/20 0.32
TSHR P16473 1/20 0.32
MAPK1 P28482 1/20 0.32
PDE2A O00408 1/20 0.31
KIF11 P52732 3/20 0.31
ALDH1A1 P00352 2/20 0.31
KDM4E B2RXH2 2/20 0.31
HTR3E A5X5Y0 1/20 0.31
HTR3B O95264 1/20 0.31
HTR3A P46098 1/20 0.31
HTR3D Q70Z44 1/20 0.31
HTR3C Q8WXA8 1/20 0.31
PKM P14618 1/20 0.31
BACE1 P56817 1/20 0.31
HPGD P15428 1/20 0.31
HSD17B10 Q99714 1/20 0.31
METAP2 P50579 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29956599 0.78 AR (0.46) PTPN5GPR3ARCES2PDE2A
SCHEMBL29956335 0.76 PTPN5 (0.34) PTPN5GPR3ARCES2TSHR
SCHEMBL29954401 0.76 PDE2A (0.44) PTPN5GPR3TSHRPDE2AALDH1A1
SCHEMBL29955691 0.73 IDO1 (0.41) PTPN5CES2TSHRMAPK1PDE2A
SCHEMBL29956146 0.73 CES2 (0.46) PTPN5GPR3ARCES2TSHR
SCHEMBL7863217 0.73 PTPN5 (0.41) PTPN5GPR3CES2TSHRMAPK1
SCHEMBL29643309 0.72 TAS2R14 (0.36) PTPN5GPR3ARCES2TSHR
SCHEMBL29954943 0.72 PDE2A (0.41) TSHRPDE2AALDH1A1
SCHEMBL319516 0.70 IDO1 (0.44) PTPN5CES2TSHRMAPK1PDE2A
SCHEMBL31371267 0.70 PTPN5 (0.39) PTPN5GPR3CES2TSHRMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115025086-A Bicyclic heteroaryl derivatives, their preparation and use 凯瑞康宁生物工程(武汉)有限公司 2022-09-09 CN disclosed
CN-110709386-B Bicyclic heteroaryl derivatives, their preparation and use 凯瑞康宁生物工程(武汉)有限公司 2022-06-07 CN disclosed